Bag3 As A Target For Therapy Of Heart Failure - EP3099333

The patent EP3099333 was granted to Temple University OF The Commonwealth System OF Higher Education on Dec 30, 2020. The application was originally filed on Jan 30, 2015 under application number EP15743948A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3099333

TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Application Number
EP15743948A
Filing Date
Jan 30, 2015
Status
Granted And Under Opposition
Oct 16, 2020
Grant Date
Dec 30, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSAug 18, 2021WILDING -

Patent Citations (38) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2009209631
DESCRIPTIONUS4235871
DESCRIPTIONUS4501728
DESCRIPTIONUS4837028
DESCRIPTIONUS5013830
DESCRIPTIONUS5034506
DESCRIPTIONUS5138045
DESCRIPTIONUS5149797
DESCRIPTIONUS5168062
DESCRIPTIONUS5218105
DESCRIPTIONUS5220007
DESCRIPTIONUS5223409
DESCRIPTIONUS5256775
DESCRIPTIONUS5350674
DESCRIPTIONUS5366878
DESCRIPTIONUS5385839
DESCRIPTIONUS5403484
DESCRIPTIONUS5403711
DESCRIPTIONUS5459255
DESCRIPTIONUS5474796
DESCRIPTIONUS5491133
DESCRIPTIONUS5565350
DESCRIPTIONUS5571698
DESCRIPTIONUS5585362
DESCRIPTIONUS5605662
DESCRIPTIONUS5623065
DESCRIPTIONUS5652355
DESCRIPTIONUS5652356
DESCRIPTIONUS5700922
DESCRIPTIONUS6127133
DESCRIPTIONWO9522618
DESCRIPTIONWO9525116
DESCRIPTIONWO9535505
INTERNATIONAL-SEARCH-REPORTEP1323733
INTERNATIONAL-SEARCH-REPORTWO2010138263
OPPOSITIONEP1323733
OPPOSITIONWO2023019272
SEARCHEP1323733

Non-Patent Literature (NPL) Citations (36) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Myocardial ischemia", Mayo Clinic, (20210505), Mayo Clinic, URL: https://www.mayoclinic.org/diseases-conditions/myocardial-ischemia/symptoms-causes/syc-20375417#, (20240306), XP093138518-
OPPOSITION- Anonymous, "REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD", REGENXBIO, (20190807), REGENXBIO, URL: https://ir.regenxbio.com/node/9196/pdf, (20240306), XP093138503-
OPPOSITION- Anonymous, "REGENXBIO’s gene ther­ apy product candidates deliver genes to cells us­ ing adeno-associated virus (AAV) vectors, which are nonreplicating viral delivery vehicles that are not known to cause disease.", NAV® Technology Platform, (20230101), NAV® Technology Platform , URL: https://www.regenxbio.com/science-innovation/nav(r)-technology-platform/, (20240306), XP093138506-
OPPOSITION- Begay, R., Et Al, "Abstract 15073: Exome Sequencing Identifies Bag3 Gene Mutation in Dilated Cardiomyopathy", Circulation, (20130101), vol. 128, no. 22 Suppl, XP055357490-
OPPOSITION- Bradley-Smith, Guy et.al., "Chapter 3 Genetic investigations; DNA SEQUENCE VARIATION AND MUTATION", Bradley-Smith, Guy et.al., GUY BRADLEY-SMITH ET AL., OXFORD HANDBOOK OF GENETICS - UNDERSTANDING GENETICS —A GUIDE FOR THE NON-SPECIALIST, Oxford, Oxford University Press, (20100101), pages 59 - 78, ISBN 978-0-19-954536-0, XP009552585-
OPPOSITION- Brancaccio M, Et Al, "Melusin gene therapy: a novel approach to fight familial dilated cardiomyopathy", European Heart Journal, (20130801), pages 641 - 641, European Heart Journal, URL: https://watermark.silverchair.com/eht309.3410.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAv4wggL6BgkqhkiG9w0BBwagggLrMIIC5wIBADCCAuAGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM3hm0eIPC54tiZACCAgEQgIICscjHE8-Yn7sVH_t0Wy-uhgkKpgVd6PnIpH-9iE_8IpHwo7F1kEiDUKojfj6WwRxucHIrBQn3zYO8FoxNc5aVVpCQ25_vEN_0QpWpcUg19GIMuWI-22k2g3LkF9BjuTYi6qlISmIeTUZqkqRHobu3Y6EUBKOuhvUu_BvCwORde3lYA78oTgXYhbAuADPmP-PrxUf7aLGb_TJz1Uiutydw0DUbuK-pXtven9JdnTAVqB4keb4MCwfGNfpNkZAojj7YBkVVyg4mSi5ydLvasYa3PJteNsvme1YVZoxgBAr6JVvLK8bfHuzvx08U-ozyhx5KnmddA-PCrMx7mJhL7_ZuZFTgqoledln0AHsZl3ssT-BGBaacFylclt1bf88T4rizqAkPNgwiORIBxd2WwyMbAwM4ZeB7_3kiNcy-3gC75vAr73rDuIKHqUhNb4YnVd0n2Aob5IhiBojWJhW8KU_s8zVz35Gcruzx1MbBFV8FYb6NRu3SvFc3aJJBmmwwntzxfNuYoDREwuJu4zfyA_0I3jECn6nr9-utdjx4oGun1LHgp9lAHW4tHQuLdOcMls1sdidlQwDL6b9gz-fyNS8eCaOk4bZAXjHC29kZjcsHWxPz3BYuBEk5_eVR82iF8CmtZpoqGCfw9OpvMwTeCYpdz7zAg1-2HtWy1LXuXJPaMjiP7kjIYvoE1d4cAtYk0Ij2QR0oFXhRGMT9CDDEg5De0DYHVkce7RQRZj_iscVuZI3wACj0HDHvX2wQfHNGcZaxXckJ3ZLUwqS0R3E-pZsh, (20211221), XP055875128-
OPPOSITION- Doonan Shawn, "The Covalent Structures of Peptides and Proteins chapter 15", Peptides and Proteins, (20020101), pages 1 - 22, XP055875090-
OPPOSITION- Knezevic Tijana, "Involvement of BAG3 in AIDS related comorbidity; HIV-1 induced cardiomyopathy", Journal of Neurovirology, (20130101), vol. 19, page s44, XP055875105-
OPPOSITION- Eric J. Rodenberg; Dimki S. Patel; Brad Shirley; Brandt W. Young; Amanda F. Taylor; Hayley R. Steidinger; Scott J. Fisher; Amit N. Patel, "Catheter‐based retrograde coronary sinus infusion is a practical delivery technique for introducing biological molecules into the cardiac system", CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, WILEY-LISS, NEW YORK, NY,, US, US , (20190313), vol. 94, no. 5, doi:10.1002/ccd.28159, ISSN 1522-1946, pages 669 - 676, XP072271713
OPPOSITION- Remme Willem J., M D, Ph D, "Overview of the relationship between ischemia and congestive heart failure", Clinical Cardiology (Hoboken), John Wiley & Sons, Inc., US, US , (20000701), vol. 23, no. S4, doi:10.1002/clc.4960230703, ISSN 0160-9289, pages IV - IV-8, XP055875115
OPPOSITION- Feldman Arthur M., Et Al, "Decreased Levels of BAG3 in a Family With a Rare Variant and in Idiopathic Dilated Cardiomyopathy", Journal of Cellular Physiology, Wiley Subscription Services, Inc., US, US , (20141101), vol. 229, no. 11, doi:10.1002/jcp.24615, ISSN 0021-9541, pages 1697 - 1702, XP055875093
OPPOSITION- Chuhong Hu, Ronald W. Busuttil, Gerald S. Lipshutz, "RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy", The Journal of Gene Medicine, John Wiley & Sons, Inc, US, US , (20100901), vol. 12, no. 9, doi:10.1002/jgm.1496, ISSN 1099-498X, pages 766 - 778, XP055308804
OPPOSITION- Mamidi Ranganath, Et Al, "Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy", Pflügers Archiv - European Journal of Physiology, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (20140201), vol. 466, no. 2, doi:10.1007/s00424-013-1412-z, ISSN 0031-6768, pages 225 - 230, XP055875110
OPPOSITION- Kratlian Razmig Garo, Hajjar Roger J., "Cardiac Gene Therapy: From Concept to Reality", CURRENT HEART FAILURE REPORTS, CURRENT SCIENCE INC., PHILADELPHIA, PA,, US, US , (20120301), vol. 9, no. 1, doi:10.1007/s11897-011-0077-1, ISSN 1546-9530, pages 33 - 39, XP055875113
OPPOSITION- Nabil Dib, Harris Khawaja, Samantha Varner, Megan Mccarthy, Ann Campbell, "Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery", Journal of Cardiovascular Translational Research, Springer US, (20110401), vol. 4, no. 2, doi:10.1007/s12265-010-9253-z, ISSN 19375387, pages 177 - 181, XP055206848
OPPOSITION- Piedallu Océane; Devos Perrine; Mougenot Nathalie; Duboscq-Bidot Laetitia; Héry Tiphaine; Vignier Nicolas; Charron Philippe; Bonne Gisèle; Villard Eric, "AAV-driven human BAG3 overexpression unexpectedly exacerbate heart failure in a LMNAH222P DCM mice model", Archives of Cardiovascular Diseases Supplements, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20220601), vol. 14, no. 2, doi:10.1016/j.acvdsp.2022.04.082, ISSN 1878-6480, page 192, XP087104819
OPPOSITION- Myers Valerie D., Et Al, "The Multifunctional Protein BAG3", JACC: Basic to Translational Science, (20180201), vol. 3, no. 1, doi:10.1016/j.jacbts.2017.09.009, ISSN 2452-302X, pages 122 - 131, XP055875080
OPPOSITION- Myers Valerie D., Gavin P. Landesberg, Marcia L. Bologna, Marc J. Semigran, Arthur M. Feldman, "Cardiac Transduction in Mini-Pigs After Low-Dose Retrograde Coronary Sinus Infusion of AAV9-BAG3", Journal of the American College of Cardiology: Basic to Translational Science, (20220101), vol. 7, no. 9, doi:10.1016/j.jacbts.2022.04.002, pages 951 - 953, XP093138513
OPPOSITION- Madhav Lavu; Susheel Gundewar; David J. Lefer;, "Gene therapy for ischemic heart disease", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY., Academic Press, GB, GB , (20100618), vol. 50, no. 5, doi:10.1016/j.yjmcc.2010.06.007, ISSN 0022-2828, pages 742 - 750, XP028189045
OPPOSITION- Xu Rui, Jia Ying, Zygmunt Deborah A., Martin Paul T., "rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart", Molecular Therapy, Elsevier Inc., US, US , (20190301), vol. 27, no. 3, doi:10.1016/j.ymthe.2019.01.005, ISSN 1525-0016, pages 636 - 649, XP093137522
OPPOSITION- Donahue J Kevin, "Cardiac gene therapy: a call for basic methods development", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20160121), vol. 387, no. 10024, doi:10.1016/S0140-6736(16)00149-5, ISSN 0140-6736, pages 1137 - 1139, XP029465173
OPPOSITION- Rosati A et al, "BAG3: a multifaceted protein that regulates major cell pathways", Cell Death & Disease, Nature Publishing Group, GB, GB , (20110401), vol. 2, doi:10.1038/cddis.2011.24, ISSN 2041-4889, pages e141 - e141-6, XP008157242
OPPOSITION- Heller Kristin N, Montgomery Chrystal L, Janssen Paul Ml, Clark K Reed, Mendell Jerry R, Rodino-Klapac Louise R, "AAV-mediated Overexpression of Human α7 Integrin Leads to Histological and Functional Improvement in Dystrophic Mice", Molecular Therapy, Elsevier Inc., US, US , (20130301), vol. 21, no. 3, doi:10.1038/mt.2012.281, ISSN 1525-0016, pages 520 - 525, XP093137518
OPPOSITION- Martin Thomas G., Myers Valerie D., Dubey Praveen, Dubey Shubham, Perez Edith, Moravec Christine S., Willis Monte S., Feldman Arthur M., Kirk Jonathan A., "Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover", Nature Communications, Nature Publishing Group, UK, UK, (20210519), vol. 12, no. 1, doi:10.1038/s41467-021-23272-z, ISSN 2041-1723, page 2942, XP093145689
OPPOSITION- Hoshino K; Kimura T; De Grand A M; Yoneyama R; Kawase Y; Houser S; Ly H Q; Kushibiki T; Furukawa Y; Ono K; Tabata Y; Frangioni J V; Kita T; Hajjar R J; Hayase M, "Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres", Gene Therapy, Nature Publishing Group, London, GB, GB , (20060518), vol. 13, no. 18, doi:10.1038/sj.gt.3302793, ISSN 0969-7128, pages 1320 - 1327, XP037772800
OPPOSITION- Christian Hinderer, Nathan Katz, Elizabeth L. Buza, Cecilia Dyer, Tamara Goode, Peter Bell, Laura K. Richman, James M. Wilson, "Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (20180301), vol. 29, no. 3, doi:10.1089/hum.2018.015, ISSN 1043-0342, pages 285 - 298, XP055532829
OPPOSITION- Kyle Chamberlain, Riyad Jalish M., Weber Thomas, "Cardiac gene therapy with adeno-associated virus-based vectors", CURRENT OPINION IN CARDIOLOGY., GOWER ACADEMIC JOURNALS, LONDON., GB, GB , (20170501), vol. 32, no. 3, doi:10.1097/HCO.0000000000000386, ISSN 0268-4705, pages 275 - 282, XP055755932
OPPOSITION- Pleger Sven T; Shan Changguang; Ksienzyk Jan; Bekeredjian Raffi; Boekstegers Peter; Hinkel Rabea; Schinkel Stefanie; Leuchs Barbara; Ludwig Jochen; Qiu Gang; Weber Christophe; Raake Philip; Koch Walter J; Katus Hugo A; Müller Oliver J; Most Patrick, "Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model", SCIENCE TRANSLATIONAL MEDICINE, American Association for the Advancement of Science (A A A S), US, US , (20110720), vol. 3, no. 92 ra 64, doi:10.1126/scitranslmed.3002097, ISSN 1946-6242, pages 117 - 126, XP008168700
OPPOSITION- Davis Jennifer, Et Al, "Lost in Transgenesis: A Userʼs Guide for Genetically Manipulating the Mouse in Cardiac Research", Circulation research, American Heart Association, Inc, Hagerstown, MD, Hagerstown, MD, doi:10.1161/CIRCRESAHA.111.262717, (20120831), pages 761 - 777, Circulation research, (20211221), XP055875122
OPPOSITION- Pleger Sven T., Raake Philip, Katus Hugo A., Most Patrick, "Cardiac Calcium Handling on Trial : Targeting the Failing Cardiomyocyte Signalosome", CIRCULATION RESEARCH, GRUNE AND STRATTON, BALTIMORE, US, US , (20140103), vol. 114, no. 1, doi:10.1161/CIRCRESAHA.113.302748, ISSN 0009-7330, pages 12 - 14, XP055875082
OPPOSITION- Hajjar Roger J., Ishikawa Kiyotake, "Introducing Genes to the Heart : All About Delivery", CIRCULATION RESEARCH, GRUNE AND STRATTON, BALTIMORE, US, US , (20170106), vol. 120, no. 1, doi:10.1161/CIRCRESAHA.116.310039, ISSN 0009-7330, pages 33 - 35, XP055875067
OPPOSITION- Kieserman Jake M. et al, "Current Landscape of Heart Failure Gene Therapy", Journal of the American Heart Association, (20190521), vol. 8, no. 10, doi:10.1161/JAHA.119.012239, XP055875076
OPPOSITION- Yamada Kelly P, Tharakan Serena, Ishikawa Kiyotake, "Consideration of clinical translation of cardiac AAV gene therapy", Cell and Gene Therapy Insights, (20200514), vol. 6, no. 5, doi:10.18609/cgti.2020.073, ISSN 2059-7800, pages 609 - 615, XP055875074
OPPOSITION- Jazwa Agnieszka; Jozkowicz Alicja; Dulak Jozef, "New vectors and strategies for cardiovascular gene therapy.", Current Gene Therapy, Bentham Science Publishers Ltd., NL, NL , (20070201), vol. 7, no. 1, doi:10.2174/156652307779940243, ISSN 1566-5232, pages 7 - 23, XP008168699
OPPOSITION- Sachiko Homma et al, "BAG3 Deficiency Results in Fulminant Myopathy and Early Lethality", Am J Pathol, doi:10.2353/ajpath.2006.060250, (20060101), pages 761 - 773060250, Am J Pathol, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698816/pdf/JPATH169000761.pdf, XP055329887
SEARCH- DUYGU SELCEN ET AL, "Mutation in BAG3 Causes Severe Dominant Childhood Muscular Dystrophy", ANNALS OF NEUROLOGY, JOHN WILEY AND SONS, BOSTON, US, (20090101), vol. 65, no. 1, doi:10.1002/ANA.21553, ISSN 0364-5134, pages 83 - 89, XP002661988 [X] 1 * page 84, column r * [A] 6-15 [I] 2-5

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents